0

COSOPT از شرکت AKORN

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COSOPT از شرکت AKORN

New Drug Application (NDA): 020869

Company: AKORN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COSOPT DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription

AT

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/07/1998 ORIG-1 Approval

Type 4 – New Combination

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20869lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20869ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020869_cosopt_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/23/2020 SUPPL-42 Labeling-Patient Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020869s042lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020869Orig1s042ltr.pdf

07/31/2015 SUPPL-40 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020869s040lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020869Orig1s040ltr.pdf

06/18/2010 SUPPL-36 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020869s036lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020869s036ltr.pdf

10/22/2008 SUPPL-34 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020869s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020869s034ltr.pdf

08/09/2006 SUPPL-30 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020869s030LTR.pdf

04/26/2006 SUPPL-28 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s026s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020869s026, s028LTR.pdf

04/26/2006 SUPPL-26 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s026s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020869s026, s028LTR.pdf

12/09/2005 SUPPL-22 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020869s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020869s022ltr.pdf

03/28/2005 SUPPL-20 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020869s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020869s020ltr.pdf

12/06/2002 SUPPL-15 Manufacturing (CMC)-Packaging

Label is not available on this site.

05/16/2002 SUPPL-13 Manufacturing (CMC)

Label is not available on this site.

04/23/2002 SUPPL-12 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20869s12lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20869s012.pdf

08/28/2002 SUPPL-11 Manufacturing (CMC)-Control

Label is not available on this site.

12/04/2001 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

12/04/2001 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

07/24/2001 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

07/19/2001 SUPPL-7 Manufacturing (CMC)-Control

Label is not available on this site.

08/24/2000 SUPPL-6 Labeling

Label is not available on this site.

11/21/2000 SUPPL-5 Manufacturing (CMC)

Label is not available on this site.

01/23/2000 SUPPL-3 Labeling

Label is not available on this site.

11/09/2000 SUPPL-2 Manufacturing (CMC)-Control

Label is not available on this site.

01/04/1999 SUPPL-1 Labeling

Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20-869-s-001_cosopt.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/23/2020 SUPPL-42

Labeling-Patient Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020869s042lbl.pdf
07/31/2015 SUPPL-40

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020869s040lbl.pdf
06/18/2010 SUPPL-36

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020869s036lbl.pdf
10/22/2008 SUPPL-34

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020869s034lbl.pdf
08/09/2006 SUPPL-30

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s030lbl.pdf
04/26/2006 SUPPL-28

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s026s028lbl.pdf
04/26/2006 SUPPL-26

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020869s026s028lbl.pdf
12/09/2005 SUPPL-22

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020869s022lbl.pdf
03/28/2005 SUPPL-20

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020869s020lbl.pdf
04/23/2002 SUPPL-12

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20869s12lbl.pdf
04/07/1998 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20869lbl.pdf

COSOPT

SOLUTION/DROPS;OPHTHALMIC; EQ 2% BASE;EQ 0.5% BASE

TE Code = AT

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
COSOPT DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription Yes AT 020869 AKORN
COSOPT PF DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription Yes AT 202667 AKORN
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 077847 AKORN
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 203058 AKORN
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 213099 ALEMBIC PHARMS LTD
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 207629 AUROBINDO PHARMA LTD
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 207630 AUROBINDO PHARMA LTD
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 090037 BAUSCH AND LOMB
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 205295 FDC LTD
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 078749 SANDOZ
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 090604 SANDOZ INC
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 207523 SOMERSET
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE EQ 2% BASE;EQ 0.5% BASE SOLUTION/DROPS;OPHTHALMIC Prescription No AT 078704 TEVA PHARMS
بخوانید  BUTALBITAL, ACETAMINOPHEN AND CAFFEINE از شرکت WATSON LABS
برچسب‌ها:

نظرات کاربران